Surgery Partners Statistics
Total Valuation
SGRY has a market cap or net worth of $1.56 billion. The enterprise value is $5.36 billion.
Important Dates
The last earnings date was Monday, March 2, 2026, after market close.
| Earnings Date | Mar 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SGRY has 129.42 million shares outstanding. The number of shares has increased by 0.86% in one year.
| Current Share Class | 128.21M |
| Shares Outstanding | 129.42M |
| Shares Change (YoY) | +0.86% |
| Shares Change (QoQ) | +0.65% |
| Owned by Insiders (%) | 1.95% |
| Owned by Institutions (%) | 68.07% |
| Float | 55.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 59.78 |
| PS Ratio | 0.47 |
| Forward PS | 0.43 |
| PB Ratio | 0.90 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 7.97 |
| P/OCF Ratio | 5.69 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 8.17, with an EV/FCF ratio of 27.39.
| EV / Earnings | n/a |
| EV / Sales | 1.62 |
| EV / EBITDA | 8.17 |
| EV / EBIT | 11.17 |
| EV / FCF | 27.39 |
Financial Position
The company has a current ratio of 1.87, with a Debt / Equity ratio of 1.15.
| Current Ratio | 1.87 |
| Quick Ratio | 1.37 |
| Debt / Equity | 1.15 |
| Debt / EBITDA | 5.43 |
| Debt / FCF | 20.65 |
| Interest Coverage | 1.76 |
Financial Efficiency
Return on equity (ROE) is 2.76% and return on invested capital (ROIC) is 5.57%.
| Return on Equity (ROE) | 2.76% |
| Return on Assets (ROA) | 3.74% |
| Return on Invested Capital (ROIC) | 5.57% |
| Return on Capital Employed (ROCE) | 6.39% |
| Weighted Average Cost of Capital (WACC) | 8.27% |
| Revenue Per Employee | $206,794 |
| Profits Per Employee | -$4,869 |
| Employee Count | 16,000 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 27.50 |
Taxes
In the past 12 months, SGRY has paid $18.00 million in taxes.
| Income Tax | 18.00M |
| Effective Tax Rate | 15.40% |
Stock Price Statistics
The stock price has decreased by -50.59% in the last 52 weeks. The beta is 1.94, so SGRY's price volatility has been higher than the market average.
| Beta (5Y) | 1.94 |
| 52-Week Price Change | -50.59% |
| 50-Day Moving Average | 14.38 |
| 200-Day Moving Average | 18.80 |
| Relative Strength Index (RSI) | 33.10 |
| Average Volume (20 Days) | 2,006,480 |
Short Selling Information
The latest short interest is 13.81 million, so 10.67% of the outstanding shares have been sold short.
| Short Interest | 13.81M |
| Short Previous Month | 16.39M |
| Short % of Shares Out | 10.67% |
| Short % of Float | 24.87% |
| Short Ratio (days to cover) | 8.50 |
Income Statement
In the last 12 months, SGRY had revenue of $3.31 billion and -$77.90 million in losses. Loss per share was -$0.61.
| Revenue | 3.31B |
| Gross Profit | 765.00M |
| Operating Income | 479.50M |
| Pretax Income | 116.90M |
| Net Income | -77.90M |
| EBITDA | 655.50M |
| EBIT | 479.50M |
| Loss Per Share | -$0.61 |
Full Income StatementBalance Sheet
The company has $239.90 million in cash and $4.04 billion in debt, with a net cash position of -$3.80 billion or -$29.35 per share.
| Cash & Cash Equivalents | 239.90M |
| Total Debt | 4.04B |
| Net Cash | -3.80B |
| Net Cash Per Share | -$29.35 |
| Equity (Book Value) | 3.53B |
| Book Value Per Share | 13.37 |
| Working Capital | 535.20M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $274.30 million and capital expenditures -$78.70 million, giving a free cash flow of $195.60 million.
| Operating Cash Flow | 274.30M |
| Capital Expenditures | -78.70M |
| Depreciation & Amortization | 176.00M |
| Net Borrowing | 162.80M |
| Free Cash Flow | 195.60M |
| FCF Per Share | $1.51 |
Full Cash Flow StatementMargins
Gross margin is 23.12%, with operating and profit margins of 14.49% and -2.35%.
| Gross Margin | 23.12% |
| Operating Margin | 14.49% |
| Pretax Margin | 3.53% |
| Profit Margin | -2.35% |
| EBITDA Margin | 19.81% |
| EBIT Margin | 14.49% |
| FCF Margin | 5.91% |
Dividends & Yields
SGRY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.86% |
| Shareholder Yield | -0.86% |
| Earnings Yield | -5.00% |
| FCF Yield | 12.54% |
Analyst Forecast
The average price target for SGRY is $22.25, which is 84.65% higher than the current price. The consensus rating is "Buy".
| Price Target | $22.25 |
| Price Target Difference | 84.65% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 8.52% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SGRY has an Altman Z-Score of 0.9 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.9 |
| Piotroski F-Score | 4 |
